Randomized trial quantifies gray matter volume changes in subcortical regions of PD-MCI, suggesting distinct neurological patterns.
Background Parkinson's disease with mild cognitive impairment (PD‐MCI) is a critical dementia prodrome, but its structural neuropathology remains incompletely defined. While hippocampal atrophy is established, volumetric changes in other subcortical structures are poorly characterized. Objective To perform the first comprehensive meta‐analysis quantifying gray matter volume alterations across six subcortical regions in PD‐MCI. Methods A systematic search of PubMed, Web of Science, Embase, and Cochrane (inception‐June 2025) for studies reporting MRI volumetric data comparing PD‐MCI and cognitively normal PD (PD‐NC) was done. Random‐effects models calculated pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs). Heterogeneity ( I 2 ), publication bias, sensitivity analyses, and meta‐regression were assessed. Results PD‐MCI showed significant bilateral atrophy versus PD‐NC in the hippocampus (total WMD = –0.65 cm 3 ), thalamus, putamen, and amygdala, alongside right‐lateralized globus pallidus atrophy (WMD = –0.08 cm 3 ). Bilateral caudate nuclei volumes were preserved. Sensitivity analyses confirmed robustness. Meta‐regression identified segmentation tools and country as sources of left hippocampal heterogeneity ( p < 0.05). No publication bias was detected. Conclusion PD‐MCI exhibits a distinct subcortical atrophy signature involving limbic–striato‐thalamic networks, with right globus pallidus atrophy as a novel lateralized biomarker. Network‐based imaging paradigms are advocated, requiring standardized protocols and longitudinal validation. Systematic Review Registration Identifier PROSPERO (CRD420251051275).
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: